AmerisourceBergen White Paper: Cell and Gene Therapy 

By AmerisourceBergen |

Cell and gene therapies promise to transform patient outcomes by unlocking cures for diseases with high-unmet need. Through our industry-leading business units, AmerisourceBergen brings expertise in each area required for successful commercialization, ranging
 from specialty logistics and market access consulting to patient support programs and the analysis of health outcomes evidence.

In this white paper, authored by our multi disciplinary and market-leading experts, readers will learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain. 

 

To access this content, please provide the below information: